Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
REVENUE	$ 12,063,345	$ 9,639,057
Cost of Revenue	3,707,064	4,197,024
GROSS PROFIT	8,356,281	5,442,033
EXPENSES
Selling, general and administrative expenses	14,612,724	17,621,865
Research and development expenses	2,571,826	3,229,879
TOTAL OPERATING EXPENSES	17,184,550	20,851,744
LOSS FROM OPERATIONS	(8,828,269)	(15,409,711)
Other income/(expense) [Notes 3, 5]	(102,607)	(110,822)
Interest expense [Notes 5, 6, 7]	(3,018,803)	(1,839,159)
Gain/(Loss) upon convertible promissory notes conversion and redemption [Note 5]	18,539	(71,119)
Accretion and amortization expenses [Notes 5, 6]	(2,172,920)	(743,459)
Change in fair value of derivative liabilities [Note 8]	9,777	(483,873)
NET LOSS BEFORE INCOME TAXES	(14,094,283)	(18,658,143)
Income taxes [Note 10]
NET LOSS BEFORE DIVIDENDS	(14,094,283)	(18,658,143)
Preferred Stock Dividends	(834,677)	(875,540)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	(14,928,960)	(19,533,683)
Translation adjustment	185,175	615,859
COMPREHENSIVE LOSS	$ (14,743,785)	$ (18,917,824)
LOSS PER SHARE, BASIC	$ (1.660)	$ (2.256)
LOSS PER SHARE, DILUTED	$ (1.660)	$ (2.256)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC	8,991,766	8,659,718
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED	8,991,766	8,659,718